Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury
- PMID: 10792114
- DOI: 10.1046/j.1365-2036.2000.00739.x
Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury
Abstract
Introduction: The harmful effects of non-steroidal anti-inflammatory drugs (NSAIDs) on the gastric mucosa and the prophylactic effects of misoprostol are both dose-dependent.
Aim: To investigate whether a low-dose of misoprostol is sufficient to prevent gastric mucosal injury caused by low-dose aspirin.
Methods: We conducted a double-blind placebo controlled parallel group endoscopic study in 32 evaluable volunteers. The main outcome measure was erosive injury (ulcers and superficial erosions) in the gastric mucosa over 28 days.
Results: Most subjects developed erosions on aspirin 300 mg daily. This was significantly reduced by misoprostol 100 microg daily. (Odds ratio 0.18, 95% CI: 0.07-0.48). There were no drug-related or gastrointestinal adverse events in subjects receiving misoprostol.
Conclusion: Misoprostol 100 microg daily can prevent low-dose aspirin induced gastric mucosal injury without causing identifiable adverse effects.
Similar articles
-
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.Clin Ther. 2004 Oct;26(10):1637-43. doi: 10.1016/j.clinthera.2004.10.002. Clin Ther. 2004. PMID: 15598480 Clinical Trial.
-
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Gastroenterol Hepatol. 2018 Jul;3(7):469-476. doi: 10.1016/S2468-1253(18)30119-5. Epub 2018 May 10. Lancet Gastroenterol Hepatol. 2018. PMID: 29754836 Clinical Trial.
-
Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.Dig Dis. 1995 Jan;13 Suppl 1:48-61. doi: 10.1159/000171526. Dig Dis. 1995. PMID: 7697902 Review.
-
Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.Ann Intern Med. 1995 Sep 1;123(5):344-50. doi: 10.7326/0003-4819-123-5-199509010-00004. Ann Intern Med. 1995. PMID: 7625622 Clinical Trial.
-
Misoprostol in the prevention of gastroduodenal damage in rheumatology.Ann Rheum Dis. 1992 Sep;51(9):1089-93. doi: 10.1136/ard.51.9.1089. Ann Rheum Dis. 1992. PMID: 1417145 Free PMC article. Review.
Cited by
-
Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.J Gastroenterol. 2011 May;46(5):612-9. doi: 10.1007/s00535-011-0385-y. Epub 2011 Feb 26. J Gastroenterol. 2011. PMID: 21359520
-
Prevention of chronic NSAID induced upper gastrointestinal toxicity.Cochrane Database Syst Rev. 2000;2002(3):CD002296. doi: 10.1002/14651858.CD002296. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2000;(4):CD002296. doi: 10.1002/14651858.CD002296. PMID: 10908548 Free PMC article. Updated.
-
Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.Intern Med. 2021 Feb 15;60(4):545-552. doi: 10.2169/internalmedicine.5097-20. Epub 2020 Oct 7. Intern Med. 2021. PMID: 33028766 Free PMC article.
-
The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries.Gastroenterol Res Pract. 2019 Jun 18;2019:6532876. doi: 10.1155/2019/6532876. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 31316561 Free PMC article.
-
Inhibition of Aspirin-Induced Gastrointestinal Injury: Systematic Review and Network Meta-Analysis.Front Pharmacol. 2021 Aug 12;12:730681. doi: 10.3389/fphar.2021.730681. eCollection 2021. Front Pharmacol. 2021. PMID: 34475825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources